Pharmacologic and nonpharmacologic approaches to the prevention and management of delirium. Int J Psychiatry Med 2016;51(2):160-70
Date
03/05/2016Pubmed ID
26941206DOI
10.1177/0091217416636578Scopus ID
2-s2.0-84977177782 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
Delirium is a syndrome of neuropsychiatric signs and symptoms that can accompany virtually any serious medical condition. Delirium is characterized by a disturbance of attention and awareness, as well as variety of other aspects of cognition that develops over a short period of time in response to another medical condition. It is an independent risk factor for increased morbidity and mortality and is associated with increased lengths of stay and costs of care. Despite this, it frequently goes unrecognized, and debate continues about the best prevention and treatment strategies. This article will review the current best practices for the prevention and treatment of delirium and how collaborative care can aid in improving outcomes and minimizing adverse events for patients suffering from delirium.
Author List
Schwartz AC, Fisher TJ, Greenspan HN, Heinrich TWAuthors
Travis J. Fisher MD Associate Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinThomas W. Heinrich MD Professor in the Psychiatry and Behavioral Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
DeliriumHumans
